Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23318443)


Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation.

Marcos-Villar L, Gallego P, Muñoz-Fontela C, de la Cruz-Herrera CF, Campagna M, González D, Lopitz-Otsoa F, Rodríguez MS, Rivas C.

Oncogene. 2014 Jan 23;33(4):495-503. doi: 10.1038/onc.2012.603. Epub 2013 Jan 14.


Structural mechanisms of DREAM complex assembly and regulation.

Guiley KZ, Liban TJ, Felthousen JG, Ramanan P, Litovchick L, Rubin SM.

Genes Dev. 2015 May 1;29(9):961-74. doi: 10.1101/gad.257568.114. Epub 2015 Apr 27.


KSHV latent protein LANA2 inhibits sumo2 modification of p53.

Laura MV, de la Cruz-Herrera CF, Ferreirós A, Baz-Martínez M, Lang V, Vidal A, Muñoz-Fontela C, Rodríguez MS, Collado M, Rivas C.

Cell Cycle. 2015;14(2):277-82. doi: 10.4161/15384101.2014.980657.


p107-Dependent recruitment of SWI/SNF to the alkaline phosphatase promoter during osteoblast differentiation.

Flowers S, Patel PJ, Gleicher S, Amer K, Himelman E, Goel S, Moran E.

Bone. 2014 Dec;69:47-54. doi: 10.1016/j.bone.2014.08.009. Epub 2014 Aug 23.


The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.

Chang PC, Cheng CY, Campbell M, Yang YC, Hsu HW, Chang TY, Chu CH, Lee YW, Hung CL, Lai SM, Tepper CG, Hsieh WP, Wang HW, Tang CY, Wang WC, Kung HJ.

BMC Genomics. 2013 Nov 23;14:824. doi: 10.1186/1471-2164-14-824.


Pocket proteins pRb and p107 are required for cortical lamination independent of apoptosis.

Svoboda DS, Paquin A, Park DS, Slack RS.

Dev Biol. 2013 Dec 1;384(1):101-13. doi: 10.1016/j.ydbio.2013.09.015. Epub 2013 Sep 19.


Sumoylation at the host-pathogen interface.

Wilson VG.

Biomolecules. 2012 Apr 5;2(2):203-27. doi: 10.3390/biom2020203.


Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzyme.

Kurimchak A, Haines DS, Garriga J, Wu S, De Luca F, Sweredoski MJ, Deshaies RJ, Hess S, Graña X.

Mol Cell Biol. 2013 Aug;33(16):3330-42. doi: 10.1128/MCB.00082-13. Epub 2013 Jun 17.


Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor.

Tomosugi M, Sowa Y, Yasuda S, Tanaka R, te Riele H, Ikawa H, Koyama M, Sakai T.

Cancer Sci. 2012 Dec;103(12):2139-43. doi: 10.1111/cas.12012. Epub 2012 Oct 26.


pRb or its cousins: who controls the family business?

Itahana K, Dimri GP.

Cell Cycle. 2012 Apr 15;11(8):1486. doi: 10.4161/cc.20048. No abstract available.


The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.

Bazarov AV, Lee WJ, Bazarov I, Bosire M, Hines WC, Stankovich B, Chicas A, Lowe SW, Yaswen P.

Cell Cycle. 2012 Mar 1;11(5):1008-13. doi: 10.4161/cc.11.5.19492. Epub 2012 Mar 1.


5-Aza-2'-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins.

Zheng Z, Li L, Liu X, Wang D, Tu B, Wang L, Wang H, Zhu WG.

FASEB J. 2012 Jan;26(1):449-59. doi: 10.1096/fj.11-190025. Epub 2011 Oct 11.


Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.

Bi X, Yang L, Mancl ME, Barnes BJ.

J Interferon Cytokine Res. 2011 Apr;31(4):373-82. doi: 10.1089/jir.2010.0084. Epub 2010 Dec 6.


Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.

Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, González-Santamaría J, González D, Rodriguez MS, Rivas C.

J Gen Virol. 2011 Jan;92(Pt 1):188-94. doi: 10.1099/vir.0.024984-0. Epub 2010 Sep 29.


Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Heinzelmann K, Scholz BA, Nowak A, Fossum E, Kremmer E, Haas J, Frank R, Kempkes B.

J Virol. 2010 Dec;84(23):12255-64. doi: 10.1128/JVI.01484-10. Epub 2010 Sep 22.


Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.

Wohlschlaeger J, Schmitz KJ, Takeda A, Takeda N, Vahlhaus C, Stypmann J, Schmid C, Baba HA.

J Heart Lung Transplant. 2010 Jan;29(1):117-24. doi: 10.1016/j.healun.2009.09.017.


Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

Chang PC, Izumiya Y, Wu CY, Fitzgerald LD, Campbell M, Ellison TJ, Lam KS, Luciw PA, Kung HJ.

J Biol Chem. 2010 Feb 19;285(8):5266-73. doi: 10.1074/jbc.M109.088088. Epub 2009 Dec 24.


Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene.

Marcos-Villar L, Lopitz-Otsoa F, Gallego P, Muñoz-Fontela C, González-Santamaría J, Campagna M, Shou-Jiang G, Rodriguez MS, Rivas C.

J Virol. 2009 Sep;83(17):8849-58. doi: 10.1128/JVI.00339-09. Epub 2009 Jun 24.


The retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells.

Harb G, Vasavada RC, Cobrinik D, Stewart AF.

Diabetes. 2009 Aug;58(8):1852-62. doi: 10.2337/db08-0759. Epub 2009 Jun 9. Erratum in: Diabetes. 2009 Oct;58(10):2425.


Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.

Lee HR, Toth Z, Shin YC, Lee JS, Chang H, Gu W, Oh TK, Kim MH, Jung JU.

J Virol. 2009 Jul;83(13):6739-47. doi: 10.1128/JVI.02353-08. Epub 2009 Apr 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk